低强度经颅聚焦超声杏仁核神经调控:双盲假对照靶点 engagement 研究与开放标签单臂临床试验
该研究在情绪、焦虑与创伤相关障碍(MATRDs)患者中,采用双盲假对照设计测试MRI引导下左侧杏仁核低强度经颅聚焦超声(tFUS)的急性BOLD信号调制效应,随后进行3周每日15次开放标签重复tFUS治疗。结果显示活性tFUS较假刺激平均降低左侧杏仁核BOLD信号,重复tFUS耐受良好且无严重不良事件,主要结局及次要结局均有显著改善。
要点
- 活性tFUS较假刺激平均降低左侧杏仁核BOLD信号,并产生海马与岛叶反应的患者相关差异
- 重复tFUS耐受良好,无严重不良事件,主要结局(Mood and Anxiety Symptom Questionnaire General Distress subscale)显著改善(p=0.001,Cohen's d=0.77)
- 次要结局Cohen's d为0.43-1.50,杏仁核对情绪刺激的激活显著降低,作者认为需双盲随机对照试验验证疗效
核心结论
- 研究发现提供初步证据表明tFUS能够调制杏仁核功能,重复tFUS在MATRDs中安全可行,并推动开展双盲随机对照试验以检验疗效。
研究设计与样本
- 靶点 engagement 研究采用双盲、受试者内、假对照设计,纳入MATRDs患者29例与健康对照23例,在功能MRI期间对左侧杏仁核施加MRI引导tFUS以检测BOLD信号的急性调制。
- 开放标签治疗试验中,同一批患者随后接受3周每日(共15次)MRI引导重复tFUS至左侧杏仁核,以检查安全性、可行性、症状变化及杏仁核对情绪面孔反应的变化。
主要发现
- 活性tFUS较假刺激平均降低左侧杏仁核BOLD信号,并产生海马和岛叶反应的患者相关差异。
- 重复tFUS耐受良好,无严重不良事件。
- 主要结局(Mood and Anxiety Symptom Questionnaire General Distress subscale)显著降低(p=0.001,Cohen's d=0.77)。
- 次要结局显著改善(Cohen's d为0.43-1.50),杏仁核对情绪刺激的激活显著降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mood, anxiety, and trauma-related disorders (MATRDs) are highly prevalent and comorbid. A sizable number of patients do not respond to first-line treatments. Non-invasive neuromodulation is a second-line treatment approach, but current methods rely on cortical targets to indirectly modulate subcortical structures, e.g., the amygdala, implicated in MATRDs. Low-intensity transcranial focused ultrasound (tFUS) is a non-invasive technique for direct subcortical neuromodulation, but its safety, feasibility, and promise as a potential treatment is largely unknown. In a target engagement study, magnetic resonance imaging (MRI)-guided tFUS to the left amygdala was administered during functional MRI (tFUS/fMRI) to test for acute modulation of blood oxygenation level dependent (BOLD) signal in a double-blind, within-subject, sham-controlled design in patients with MATRDs (N = 29) and healthy comparison subjects (N = 23). In an unblinded treatment trial, the same patients then underwent 3-week daily (15 sessions) MRI-guided repetitive tFUS (rtFUS) to the left amygdala to examine safety, feasibility, symptom change, and change in amygdala reactivity to emotional faces. Active vs. sham tFUS/fMRI reduced, on average, left amygdala BOLD signal and produced patient-related differences in hippocampal and insular responses. rtFUS was well-tolerated with no serious adverse events. There were significant reductions on the primary outcome (Mood and Anxiety Symptom Questionnaire General Distress subscale; p = 0.001, Cohen's d = 0.77), secondary outcomes (Cohen's d of 0.43-1.50), and amygdala activation to emotional stimuli. Findings provide initial evidence of tFUS capability to modulate amygdala function, rtFUS safety and feasibility in MATRDs, and motivate double-blind randomized controlled trials to examine efficacy.ClinicalTrials.gov registration: NCT05228964.
引用
- Barksdale BR, Enten L, DeMarco A, et al. Low-intensity transcranial focused ultrasound amygdala neuromodulation: a double-blind sham-controlled target engagement study and unblinded single-arm clinical trial. Mol Psychiatry. 2025. PMID: 40275098. doi:10.1038/s41380-025-03033-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。